These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37171267)

  • 1. Posttranscriptional regulation of the prostaglandin E receptor spliced-isoform EP3-γ and its implication in pancreatic β-cell failure.
    Srivastava R; Horwitz M; Hershko-Moshe A; Bronstein S; Ben-Dov IZ; Melloul D
    FASEB J; 2023 Jun; 37(6):e22958. PubMed ID: 37171267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Cox-2 and prostaglandin E
    Amior L; Srivastava R; Nano R; Bertuzzi F; Melloul D
    FASEB J; 2019 Apr; 33(4):4975-4986. PubMed ID: 30629897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological blockade of the EP3 prostaglandin E
    Bosma KJ; Andrei SR; Katz LS; Smith AA; Dunn JC; Ricciardi VF; Ramirez MA; Baumel-Alterzon S; Pace WA; Carroll DT; Overway EM; Wolf EM; Kimple ME; Sheng Q; Scott DK; Breyer RM; Gannon M
    Mol Metab; 2021 Dec; 54():101347. PubMed ID: 34626853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 receptor, EP3, is induced in diabetic islets and negatively regulates glucose- and hormone-stimulated insulin secretion.
    Kimple ME; Keller MP; Rabaglia MR; Pasker RL; Neuman JC; Truchan NA; Brar HK; Attie AD
    Diabetes; 2013 Jun; 62(6):1904-12. PubMed ID: 23349487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of prostaglandin E
    Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
    Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EP3 receptor isoforms are differentially expressed in subpopulations of primate granulosa cells and couple to unique G-proteins.
    Kim SO; Dozier BL; Kerry JA; Duffy DM
    Reproduction; 2013 Dec; 146(6):625-35. PubMed ID: 24062570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance.
    Wisinski JA; Reuter A; Peter DC; Schaid MD; Fenske RJ; Kimple ME
    Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E479-E489. PubMed ID: 34229444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 receptor EP3 regulates both adipogenesis and lipolysis in mouse white adipose tissue.
    Xu H; Fu JL; Miao YF; Wang CJ; Han QF; Li S; Huang SZ; Du SN; Qiu YX; Yang JC; Gustafsson JÅ; Breyer RM; Zheng F; Wang NP; Zhang XY; Guan YF
    J Mol Cell Biol; 2016 Dec; 8(6):518-529. PubMed ID: 27436752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA
    Li J; Du H; Zhang M; Zhang Z; Teng F; Zhao Y; Zhang W; Yu Y; Feng L; Cui X; Zhang M; Lu T; Guan F; Chen L
    Int J Biol Sci; 2019; 15(7):1533-1545. PubMed ID: 31337982
    [No Abstract]   [Full Text] [Related]  

  • 10. PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.
    Hassouneh R; Nasrallah R; Zimpelmann J; Gutsol A; Eckert D; Ghossein J; Burns KD; Hébert RL
    Diabetologia; 2016 Jun; 59(6):1318-28. PubMed ID: 26995650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat prostaglandin EP3 receptor is highly promiscuous and is the sole prostanoid receptor family member that regulates INS-1 (832/3) cell glucose-stimulated insulin secretion.
    Sandhu HK; Neuman JC; Schaid MD; Davis SE; Connors KM; Challa R; Guthery E; Fenske RJ; Patibandla C; Breyer RM; Kimple ME
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00736. PubMed ID: 33694300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice.
    Ceddia RP; Lee D; Maulis MF; Carboneau BA; Threadgill DW; Poffenberger G; Milne G; Boyd KL; Powers AC; McGuinness OP; Gannon M; Breyer RM
    Endocrinology; 2016 Jan; 157(1):220-32. PubMed ID: 26485614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the presence of a critical disulfide bond in the mouse EP3γ receptor.
    Downey JD; Sanders CR; Breyer RM
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):53-8. PubMed ID: 21236356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different membrane targeting of prostaglandin EP3 receptor isoforms dependent on their carboxy-terminal tail structures.
    Hasegawa H; Katoh H; Yamaguchi Y; Nakamura K; Futakawa S; Negishi M
    FEBS Lett; 2000 May; 473(1):76-80. PubMed ID: 10802063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elovl6 Deficiency Improves Glycemic Control in Diabetic
    Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic analysis of prostaglandin E
    Normand C; Breton B; Salze M; Barbeau E; Mancini A; Audet M
    Eur J Pharmacol; 2022 Jul; 927():175043. PubMed ID: 35598847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
    Han D; Yamamoto Y; Munesue S; Motoyoshi S; Saito H; Win MT; Watanabe T; Tsuneyama K; Yamamoto H
    Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis.
    Ueta M; Matsuoka T; Narumiya S; Kinoshita S
    J Allergy Clin Immunol; 2009 Feb; 123(2):466-71. PubMed ID: 18996575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E
    Neuman JC; Schaid MD; Brill AL; Fenske RJ; Kibbe CR; Fontaine DA; Sdao SM; Brar HK; Connors KM; Wienkes HN; Eliceiri KW; Merrins MJ; Davis DB; Kimple ME
    Diabetes; 2017 Jun; 66(6):1572-1585. PubMed ID: 28193789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT3 Overexpression Attenuates Palmitate-Induced Pancreatic β-Cell Dysfunction.
    Kim M; Lee JS; Oh JE; Nan J; Lee H; Jung HS; Chung SS; Park KS
    PLoS One; 2015; 10(4):e0124744. PubMed ID: 25915406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.